FDA In Transition: How Regulatory Shifts Are Redefining Drug Development

In the first episode of Novotech’s new podcast series, Navigating Regulatory Changes & Market Dynamics: CRO Perspectives on the Future of Clinical Trials, regulatory leaders explore how recent shifts at the FDA are impacting the global clinical trial landscape.

Listen to learn:

• How FDA transitions are shaping new regulatory priorities
• Sponsor perspectives on conducting trials in the US vs. global markets
• Emerging trends in pipeline strategy and investment focus